Siggaard-Andersen, J.: Venous occlusion plethysmography on the calf. Evaluation of diagnosis and results in vascular surgery. Munksgaard Inc., Copenhagen, 1970.
2.
Siggaard-Andersen, J.: Obliterative vascular disease. Classification by means of the Dohn plethysmograph. Acta chir Scand., 130: 190, 1965.
3.
Siggaard-Andersen, J., Petersen, F.B. & Kjeldsen , K.: Volume changes of the calf during ten minutes' venous stasis. Acta med. Scand. , 184: 289, 1968.
4.
Rothlin, E., and Cerletti, A.: Pharmakologie des Hochdrucks. Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung, 15, 1949.
5.
Barcroft, H., and Swan, H.J.C.: Sympathetic control of human blood vessels, p. 96. Edward Arnold, London1953.
6.
Goetz, R.H., and Katz, A.: The adrenolytic action of dihydroergocornine in man. Lancet , I: 560, 1949.
7.
Kappert, A., and Hadorn, W.: Experimental and therapeutic investigations with certain new hydrogenated ergot alkaloids in peripheral vascular disorders. Angiology . 1: 520, 1950.
8.
Frank, N., Nakano, J., and Baldani, C.F.: The effect of Hydergine on peripheral vascular disease. J. med. soc. New Jersey, 53: 12, 1956.
9.
Samuels, S.S. , and Tuchman, M.: Arteriosclerosis obliterans. I. Plethysmographic studies of peripheral circulation following administration of vasodilators . Angiology, 6: 1, 1955.
10.
Luke, J.C., and Marien, B.N.: Hydrogenated ergot alkaloids in treatment of intermittent claudication . Canad. M. A. J., 68: 221, 1953.
11.
Vogler, E.: Angiographische Beiträge zur Entstehung von Gefäserkrankungen und Durchblutungsstörungen unter besonderer Berücksichtigung der terminalen Strombahn . Fortschr. Röntgenstr., 81: 479, 1954.
12.
Nieth, H., Zeh, E., and Jensbach, W.: Behandlung arterieller Durchblutnngsstörungen mit Hydergin. Die Medizinische, 1116, 1952.
13.
Bruck, H., and Weil, P.: Vorläugfige Ergebnisse mit Hydergin zur Verbesserung der peripheren Durchblutung . Wiener Med. Wochenschr., 106: 757, 1956 .
14.
Barcroft, H.Konzett, H., and Swan, H.J.C.: Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in man. J. Physiol., 112: 273, 1951 .
15.
Gillespie. J.A. , and Douglas, D.M.: Some aspects of obliterative vascular disease of the lower limb, p. 49. E. & S. Livingstone Ltd., Edinburgh and London, 1961.
16.
Bartlett, M.S. : Properties of sufficiency and statistical tests . Proc. Roy. Soc. London, Series A, 160: 268, 1937.
